The industry of western medicine is steeped in corruption, dishonesty and dirty tricks. One of those dirty tricks became apparent recently when it was revealed that a superbug discovered by western researchers was given the name "New Delhi" in order to make westerners fearful of medical tourism in India.
Medical tourism, you see, is hurting the profits of western hospitals and medical clinics who vastly overcharge for their services. By traveling to India or other countries, patients from western nations can receive virtually identical medical care at a small fraction of the price normally charged in America or other western nations. But the conventional medical industry cannot tolerate people having a free choice about much of anything, so they engage in dirty tricks to scare people into buying health care services at monopolistic prices.
One of the more recent dirty tricks involves the discovery of a drug-resistant superbug in several UK patients. Because some of those patients (but not all) had traveled to India, the UK researcher decided to disparage India's medical tourism industry and name the superbug "New Delhi." Or, more specifically, "New Delhi metallo-beta-lactamase 1 (NDM-1)."
The name of this superbug was chosen to link "superbug" with "India" and "medical tourism," thereby scaring people away from even thinking of traveling to India for medical tourism.
Does anyone seriously think Horton would have allowed a superbug to be named "London" without considering the implications? Of course not. So why would he use the name "New Delhi" which is the geopolitical equivalent?
So there you have it: A superbug named to discredit medical tourism, a weak apology from a medical journal editor but no action to change the name. So this superbug will continue to be called "New Delhi" and it will continue to discredit the entire nation of India which, of course, was the whole idea to begin with.